2-Cyclobutyl-2-oxoacetic acid, 95+%, 250mg

2,2-Difluoro-2-(thiazol-5-yl)acetic acid, 98%, 250mg

2-Chloro-5-(2-hydroxyethyl)benzaldehyde, 98%, 50mg

4-Aminonicotinonitrile, 95.0%, 100mg

(1R,3S,Z)-3-(tert-butyldimethylsilyloxy)-5-((E)-2-((1R,3aS,7aR)-1-((R)-6-hydroxy-6-methylheptan-2-yl)-7a-methyldihydro-1H-inden-4(2H,5H,6H,7H,7aH)-ylidene)ethylidene)-4-methylenecyclohexanol, 98%, 5mg

TLC Plates CEL 300 / UV254, 5 x 20 cm, 100 Piece(s)

Salicylic acid, min. 99%, pa, ACS, 500 g, plastic packaging.

Ruthenium dioxide hydrate, 95.0%, 5g

(S)-5-Aminopiperidin-2-one hydrochloride, 95.0%, 250mg

tert-Butyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indoline-1-carboxylate, 95.0%, 10g

4,6-Dichloro-5-methoxypyrimidine, 98.0%, 500g

2-tert-Butyl-4-chloro-6-methylpyrimidine, 95.0%, 5g

6-Hydroxyflavanone>98.0%(GC)(T)1g